StonvexLoading…
StonvexCore line items from CHPT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-01-31 | Annual 2024 2024-01-31 | Annual 2023 2023-01-31 |
|---|---|---|---|---|
Revenue | $411.22M | $417.08M | $506.64M | $468.09M |
Operating Income | $-210.14M | $-253.00M | $-449.95M | $-341.78M |
Net Income | $-220.20M | $-277.07M | $-457.61M | $-345.11M |
EPS (Diluted) | $-9.41 | $-12.78 | $-24.37 | $-1.02 |
Total Assets | $792.25M | $898.17M | $1.10B | $1.08B |
Total Liabilities | $770.95M | $760.70M | $775.69M | $724.97M |
Cash & Equivalents | $141.56M | $224.57M | $327.41M | $264.16M |
Free Cash Flow OCF − CapEx | $-67.00M | $-159.02M | $-348.37M | $-285.61M |
Shares Outstanding | 24.32M | 22.81M | 421.12M | 348.33M |